PureTech Health plc (LON:PRTC – Get Free Report) shares passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 153.73 ($2.00) and traded as high as GBX 155.58 ($2.02). PureTech Health shares last traded at GBX 151.20 ($1.96), with a volume of 421,616 shares traded.
PureTech Health Trading Down 2.1 %
The company has a fifty day moving average of GBX 153.73 and a two-hundred day moving average of GBX 185.19. The company has a current ratio of 3.68, a quick ratio of 2.51 and a debt-to-equity ratio of 47.27. The stock has a market capitalization of £362.00 million, a price-to-earnings ratio of -657.39 and a beta of 1.02.
PureTech Health Company Profile
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Read More
- Five stocks we like better than PureTech Health
- How to Start Investing in Real Estate
- Texas Roadhouse Stock Steering for New Highs This Year
- Why Are These Companies Considered Blue Chips?
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Top Stocks Investing in 5G Technology
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
